ORIGINAL RESEARCH article
Front. Psychiatry
Sec. Addictive Disorders
Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1647269
The Evolving Burden of Drug Use Disorders: A Comprehensive Epidemiological Analysis from the 2021 global burden of disease study
Provisionally accepted
- 1Jinshan Hospital, Fudan University, Shanghai, China
- 2Fudan University, Shanghai, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Drug use disorders (DUDs) pose a substantial global health burden, yet comprehensive analyses of their epidemiological trends, sociodemographic drivers, and cross-national disparities remain limited. Leveraging data from the Global Burden of Disease (GBD) 2021 study, we evaluated the global, regional, and national burden of DUDs from 1990 to 2021, focusing on opioids, cannabis, cocaine, amphetamines, and other substances.Using GBD 2021 data, we analyzed age-standardized incidence, prevalence, mortality, and disability-adjusted life years (DALYs) for DUDs across 204 countries. Bayesian metaregression (DisMod-MR 2.1) and age-period-cohort modeling were applied to quantify trends, stratified by sex, age, region, and socio-demographic Index (SDI). Uncertainty intervals (UIs) were derived from 1,000 posterior draws.Globally, incident DUD cases increased by 36% (95% UI: 31%-40%) from 1990 to 2021, while mortality more than doubled (122%, 95% UI: 100%-149%). Despite an 8% decline in age-standardized incidence rates (184.31 to 169.39 per 100,000), mortality rates rose by 31% (1.26 to 1.65 per 100,000), and DALYs increased by 15% (166.44 to 190.97 per 100,000). High-income North America experienced an 11.2-fold surge in mortality (6,125 to 74,451 deaths), contrasting with East Asia's 15% reduction in incident cases. Opioidrelated DALYs rose by 32% (103.69 to 137.15 per 100,000), driven by high-SDI regions, while cocaine-related mortality doubled (108%, 0.07 to 0.15 per 100,000). Males aged 20-24 had 1.35-fold higher incidence than females (386.01 vs. 285.59 per 100,000), with mortality peaking at ages 25-29 (3.45 vs. 1.12 per 100,000). SDI exhibited a strong positive correlation with DALYs (Spearman ρ=0.70, *p*<0.01), though amphetamine use disorders peaked at moderate SDI levels (0.6-0.8).The escalating mortality and DALYs despite declining incidence highlight systemic gaps in harm reduction and treatment access, particularly in high-SDI nations. Opioid and cocaine crises demand urgent regulatory reforms and integrated care models. Global disparities underscore the need for context-specific interventions addressing socioeconomic determinants, polysubstance use, and aging populations. Policymakers must prioritize data-driven strategies aligned with SDG 3 targets (good health and well-being) to mitigate the growing burden of DUDs.
Keywords: Global burden of disease, drug use disorders, socio-demographic index, opioid, Health Disparities
Received: 16 Jun 2025; Accepted: 04 Aug 2025.
Copyright: © 2025 Liu, Zhang, Ren, Lv, Ran, Tan and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ning Zhang, Jinshan Hospital, Fudan University, Shanghai, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.